Model Number 3CX*FX25RWC |
Device Problem
Leak/Splash (1354)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/04/2023 |
Event Type
malfunction
|
Event Description
|
The user facility reported to terumo cardiovascular during cardiopulmonary bypass, there was plasma leakage.As per the user facility, the plasma leakage was observed during the extracorporeal activity.The oxygenator was deteriorating; thus the oxygenator was changed out.Patient's height: 170 cm.No consequences or impact to patient.The product was changed out.The surgery was completed successfully.
|
|
Manufacturer Narrative
|
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code 11.H6: component code: 4739 - gas exchanger.Health effect - impact code: 2199 - no health consequences or impact.Health effect - clinical code: 4582 - no clinical, signs, symptoms or conditions.Medical device problem code: 1354 - leak/splash.Investigation findings: 3233 - results pending completion of investigation.Investigation conclusions: 11 - conclusion not yet available.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on (b)(6), 2023.Upon further investigation of the reported event, the following information is new and/or changed: d9 (device availability - added date returned to manufacturer) g2 (updated report source) g3 (date received by manufacturer) g6 (indication that this is a follow-up report) h2 (follow-up due to additional information) h3 (device evaluation anticipated by manufacturer - a second follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references conclusions code 11.) all available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Event Description
|
Plasma leak.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added exp date); g3 (date received by manufacturer) ; g6 (indication that this is a follow-up report) ; h2 (follow-up due to additional information and device evaluation) ; h3 (device evaluated by manufacturer) ; h4 (device manufacture date); h6 (identification of evaluation codes 10, 3331, 213, 67).Type of investigation #1: 10 - testing of actual/suspected device.Type of investigation #2: 3331 - analysis of production records.Investigation findings: 213 - no device problem found.Investigation conclusions: 67 - no problem detected.The returned sample was visually inspected upon receipt with no anomaly such as breakage.The unit was then tested, after it was rinsed, the blood channel was filled with colored saline solution, and no leakage was observed.The blood outlet port was blocked, and air pressure of 2kgf/cm2 was applied to the blood channel from the blood inlet port.No leakage was observed inside the housing at the gas channel side.History investigation of the involved product code / lot number was found to have no anomaly in the manufacturing record, and the product inspection record.Based on the investigation results, the definitive cause of the plasma leak could not be clarified.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Event Description
|
Plasma leak.
|
|
Search Alerts/Recalls
|
|